|
Effect of Pharmaceutical Care with Empowerment in Type 2 Diabetic Patients at Mettapracharak (Watraikhing) Hospital |
|---|---|
| รหัสดีโอไอ | |
| Creator | Sommanat Manatphaiboon |
| Title | Effect of Pharmaceutical Care with Empowerment in Type 2 Diabetic Patients at Mettapracharak (Watraikhing) Hospital |
| Contributor | Sommanat Manatphaiboon, Pagamas Maitreemit, Sarawut Oo-puthinan |
| Publisher | Faculty of Pharmaceutical Sciences KKU MSU UBU |
| Publication Year | 2560 |
| Journal Title | Isan Journal of Pharmaceutical Sciences |
| Journal Vol. | 13 |
| Journal No. | 1 |
| Page no. | 37-51 |
| Keyword | Pharmaceutical care, Empowerment, Type 2 diabetic patient, Drug therapy problem, Medication adherence |
| URL Website | https://tci-thaijo.org/index.php/IJPS |
| Website title | Isan Journal ofPharmaceutical Sciences, IJPS |
| ISSN | 19050852 |
| Abstract | Introductions: Empowerment process allows diabetic patients to discover their potential to control the disease and to increase their cooperation in the treatment while pharmaceutical care helps to find and solve drug therapy ploblems. Together, pharmaceutical care with empowerment may more effectively improve blood sugar control in diabetic patients with uncontrolled high blood sugar. Purpose: To compare clinical outcomes i.e. HbA1c and fasting plasma glucose (FPG), medication adherence, general knowledge about diabetes and quality of life in diabetic patients before and after a pharmaceutical care program with empowerment. Method: This one group pretest-posttest study was conducted in diabetic patients with HbA1c > 7% during April to December 2015. Twenty-nine outpatients were purposively recruited from diabetes mellitus clinic and were provided with a pharmaceutical care program based on Gibson's empowerment framework. The program activity consisted of medication review for finding drug therapy problems and empowerment processes in four steps including 1) discovering reality, 2) critical reflection, 3) taking charge, and 4) holding on. Each visit was at least 1 month apart according to the doctor 's appointments. The main outcome was HbA1c. Medication adherences were determined using both percent pill count and Morisky Medication Adherence Scale-4 items or MMAS-4. General diabetes knowledge was measured by Supakit Wongwiwatthananukit 's quesionnaire and quality of life by Thai version of Diabetes-39 quesionnaire or D-39. Results: The mean HbA1c and FPG were significantly decreased from 9.4% to 8.0% and from 232 to 173 mg/dL. at the end of study, respectively (p < 0.001). In accordance with HbA1c and FPG, the medication adherence was significantly increased from 75% to 91% by average percentage pill count and from 1 to 4 by median MMAS-4 scores. The mean patient's diabetes knowledge score was also increased from 15 to 21 (p < 0.001 for all tests). In addition, the D-39 quality of life scores were significantly improved in all 4 dimensions (p < 0.001) except sexual behavior dimension. Conclusion: The pharmaceutical care service with empowerment framework might help improve blood glucose control, medication adherence, general diabetes knowledge and quality of life in type 2 DM patients with high blood sugar. |
